Imunon, Inc. Total Long-Term Debt
Imunon, Inc. (IMNN) had Total Long-Term Debt of $6.08 million as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2023-05-11
- 2023-03-31: Long-term Debt $6.08M.
- 2022-12-31: Long-term Debt $5.96M.
- 2022-09-30: Long-term Debt $5.99M.
- 2022-06-30: Long-term Debt $5.95M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2023-03-31 | $6.08M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.96M 10-K · filed 2023-03-30 | |
| 2022-09-30 | $5.99M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $5.95M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $5.90M 10-Q · filed 2022-05-16 | |
| 2021-09-30 | $5.85M 10-K · filed 2022-03-31 | $5.81M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.76M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $5.09M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $5.05M 10-K · filed 2021-03-19 | |
| 2020-09-30 | $5.04M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $10.00M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $9.90M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $9.80M 10-K · filed 2020-03-25 | |
| 2019-09-30 | $9.71M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $9.61M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $9.51M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $9.42M 10-K · filed 2019-03-29 | |
| 2018-09-30 | $9.32M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $9.22M 10-Q · filed 2018-08-14 | |
| 2014-06-30 | $10.00M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $5.00M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $5.00M 10-K · filed 2014-03-13 | |
| 2013-09-30 | $4.26M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $4.71M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $5.00M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $5.00M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $5.00M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $5.00M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |